2008
DOI: 10.1002/pd.1924
|View full text |Cite
|
Sign up to set email alerts
|

Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations

Abstract: For exclusion of genetic disease, day 5-6 blastocyst-stage biopsies are more likely to be followed by implantation and singleton births than is the case after PGD performed on day 3.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
42
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(44 citation statements)
references
References 32 publications
1
42
0
1
Order By: Relevance
“…In women undergoing pre-implantation genetic screening (PGS), embryos can be transferred when a result becomes available, on day 5 or on day 6 [14]. These patients might also be encouraged to have their tested blastocysts transferred one at a time whether on day 5 or day 6 to avoid multiple pregnancies [15]. These results are also potentially useful to busy units as it allows flexibility in scheduling patients for BET to avoid fluctuations in work load and working in weekends.…”
Section: Resultsmentioning
confidence: 96%
“…In women undergoing pre-implantation genetic screening (PGS), embryos can be transferred when a result becomes available, on day 5 or on day 6 [14]. These patients might also be encouraged to have their tested blastocysts transferred one at a time whether on day 5 or day 6 to avoid multiple pregnancies [15]. These results are also potentially useful to busy units as it allows flexibility in scheduling patients for BET to avoid fluctuations in work load and working in weekends.…”
Section: Resultsmentioning
confidence: 96%
“…Implementing PGS on blastocysts resulted in better pregnancy and implantation rates compared to the transfer of genetically screened cleavage stage embryos. This is related to the higher accuracy of genetic diagnosis at the blastocyst stage from the availability of more nuclear material from multiple cells and performing the screening on a more selected pool of embryos than that available at cleavage stage [9]. Delaying PGS to the blastocyst stage limits the number screened embryos to only more competent embryos minimizing the costs of screening and maximizing the accuracy of diagnosis [9][10][11].…”
Section: Introductionmentioning
confidence: 97%
“…A day 5 blastocyst, rather than a day 3 blastocyst, was used for biopsy in order to have developmentally more competent embryos for diagnosis. Such an approach has been suggested to have technical advantages and an improved pregnancy rate [16,17]. Nonetheless, misdiagnosis can occur during PGD, and several types of errors causing adverse pregnancy outcomes have been reported [18].…”
Section: Discussionmentioning
confidence: 99%